Cutler Group LP Aquestive Therapeutics, Inc. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$3.69 - $6.37 $1,107 - $1,911	-300 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$3.25 - $4.66 $325 - $466	-100 Reduced 25.0%	300 $1,000
Q2 2021 Jul 19, 2021	SELL	$3.29 - $5.21 $5,922 - $9,378	-1,800 Reduced 81.82%	400 $1,000
Q1 2021 Apr 26, 2021	SELL	$4.17 - $6.73 $3,753 - $6,057	-900 Reduced 29.03%	2,200 $11,000
Q4 2020 Jan 21, 2021	BUY	$4.65 - $7.79 $14,415 - $24,149	3,100 New	3,100 $16,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $245M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.